Paper31387285
Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets.
Wang Z and 9 others. Viruses, 2019. Cited by 21 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets. Papers, record 31387285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31387285
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Enzymes | Major topic |
| Streptococcal Infections | Major topic |
| Swine Diseases | Major topic |
| Animals | |
| Bacterial Load | |
| Bacteriolysis | |
| Interleukin-6 | |
| Mice | |
| Microbial Sensitivity Tests | |
| Serogroup | |
| Streptococcus suis | |
| Swine | |
| Treatment Outcome |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,816,840 | Distribution of Streptococcus suis capsular types in 1999. | Can Vet J | 2000 | https://conductscience.org/library/papers/10816840 | PubMed |
| 2 | 11,259,652 | Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11259652 | PubMed |
| 3 | 21,098,252 | A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21098252 | PubMed |
| 4 | 2,170,533 | Removal of endotoxin from protein solutions by phase separation using Triton X-114. | J Immunol Methods | 1990 | https://conductscience.org/library/papers/2170533 | PubMed |
| 5 | 21,984,241 | Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. | Appl Environ Microbiol | 2011 | https://conductscience.org/library/papers/21984241 | PubMed |
| 6 | 23,043,507 | Diversity in bacterial lysis systems: bacteriophages show the way. | FEMS Microbiol Rev | 2013 | https://conductscience.org/library/papers/23043507 | PubMed |
| 7 | 23,951,285 | Development of multiplex PCR assays for the identification of the 33 serotypes of Streptococcus suis. | PLoS One | 2013 | https://conductscience.org/library/papers/23951285 | PubMed |
| 8 | 24,575,098 | The Interplay between Daptomycin and the Immune System. | Front Immunol | 2014 | https://conductscience.org/library/papers/24575098 | PubMed |
| 9 | 24,957,086 | Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 2. | Future Microbiol | 2014 | https://conductscience.org/library/papers/24957086 | PubMed |
| 10 | 25,895,090 | Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis. | Appl Microbiol Biotechnol | 2015 | https://conductscience.org/library/papers/25895090 | PubMed |
| 11 | 26,038,745 | Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. | Emerg Microbes Infect | 2014 | https://conductscience.org/library/papers/26038745 | PubMed |
| 12 | 26,253,669 | Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections. | Appl Environ Microbiol | 2015 | https://conductscience.org/library/papers/26253669 | PubMed |
| 13 | 26,505,485 | Streptococcus suis Meningitis: A Systematic Review and Meta-analysis. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26505485 | PubMed |
| 14 | 26,534,896 | A novel endolysin disrupts Streptococcus suis with high efficiency. | FEMS Microbiol Lett | 2015 | https://conductscience.org/library/papers/26534896 | PubMed |
| 15 | 26,856,847 | Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26856847 | PubMed |
| 16 | 26,978,792 | A bacteriophage endolysin that eliminates intracellular streptococci. | Elife | 2016 | https://conductscience.org/library/papers/26978792 | PubMed |
| 17 | 27,131,836 | Monitoring of antimicrobial susceptibility of Streptococcus suis in the Netherlands, 2013-2015. | Vet Microbiol | 2016 | https://conductscience.org/library/papers/27131836 | PubMed |
| 18 | 27,379,064 | SLPW: A Virulent Bacteriophage Targeting Methicillin-Resistant Staphylococcus aureus In vitro and In vivo. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27379064 | PubMed |
| 19 | 27,385,518 | LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27385518 | PubMed |
| 20 | 27,481,700 | A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection. | FEMS Microbiol Lett | 2016 | https://conductscience.org/library/papers/27481700 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,953,439 | Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41953439 | PubMed |
| 41,824,190 | Bacteriophage Lysins as Programmable Antimicrobials: Mechanisms, Engineering, and Translational Advances. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41824190 | PubMed |
| 41,600,721 | Antibacterial Activity of Bacteriophage Lytic Enzyme Ply900. | Vet Sci | 2026 | https://conductscience.org/library/papers/41600721 | PubMed |
| 40,970,331 | Next-generation antimicrobials: A review of phage lysins as precision weapons against drug-resistant pathogens. | Virulence | 2025 | https://conductscience.org/library/papers/40970331 | PubMed |
| 40,810,777 | The Application and Limitations of Promising Biological Therapies in Livestock Production under the Context of Antibiotic Restrictions. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/40810777 | PubMed |
| 40,428,088 | Bacteriophages as Targeted Therapeutic Vehicles: Challenges and Opportunities. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40428088 | PubMed |
| 40,196,032 | Surface display of Lys0859, a Streptococcus suis prophage lysin, on Bacillus subtilis spores and its antibacterial activity against Streptococcus suis. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40196032 | PubMed |
| 40,071,209 | Biological function identification of phage holin Hol-4086 and treatment of Staphylococcus aureus infection. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40071209 | PubMed |
| 39,981,314 | Therapeutic efficacy of LysGH15 against necrotising pneumonia caused by Staphylococcus aureus in a rabbit model. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/39981314 | PubMed |
| 39,934,866 | Development of a novel chimeric lysin to combine parental phage lysin and cefquinome for preventing sow endometritis after artificial insemination. | Vet Res | 2025 | https://conductscience.org/library/papers/39934866 | PubMed |
| 39,309,956 | Bacteriophage as a potential biotherapeutics to combat present-day crisis of multi-drug resistant pathogens. | Heliyon | 2024 | https://conductscience.org/library/papers/39309956 | PubMed |
| 38,666,970 | Bacteriophage Therapy in Companion and Farm Animals. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38666970 | PubMed |
| 36,935,353 | The applications of animal models in phage therapy: An update. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/36935353 | PubMed |
| 36,371,221 | How Streptococcus suis escapes antibiotic treatments. | Vet Res | 2022 | https://conductscience.org/library/papers/36371221 | PubMed |
| 36,146,802 | From Farm to Fork: Streptococcus suis as a Model for the Development of Novel Phage-Based Biocontrol Agents. | Viruses | 2022 | https://conductscience.org/library/papers/36146802 | PubMed |
| 33,808,027 | The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease. | Molecules | 2021 | https://conductscience.org/library/papers/33808027 | PubMed |
| 32,069,940 | The Impact and Applications of Phages in the Food Industry and Agriculture. | Viruses | 2020 | https://conductscience.org/library/papers/32069940 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31387285
GET https://conductscience.org/api/papers/v1/31387285/references?page=2